BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20639112)

  • 21. Quinone reductase induction as a biomarker for cancer chemoprevention.
    Cuendet M; Oteham CP; Moon RC; Pezzuto JM
    J Nat Prod; 2006 Mar; 69(3):460-3. PubMed ID: 16562858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer chemopreventive activity mediated by 4'-bromoflavone, a potent inducer of phase II detoxification enzymes.
    Song LL; Kosmeder JW; Lee SK; Gerhäuser C; Lantvit D; Moon RC; Moriarty RM; Pezzuto JM
    Cancer Res; 1999 Feb; 59(3):578-85. PubMed ID: 9973203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Searching phase II enzymes inducers, from Michael acceptor-[1,2]dithiolethione hybrids, as cancer chemopreventive agents.
    Couto M; de Ovalle S; Cabrera M; Cerecetto H; González M
    Future Med Chem; 2015; 7(7):857-71. PubMed ID: 26061105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells.
    Miranda CL; Aponso GL; Stevens JF; Deinzer ML; Buhler DR
    Cancer Lett; 2000 Feb; 149(1-2):21-9. PubMed ID: 10737704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cytotoxic mechanisms of anticancer hydroxychalcones.
    Sabzevari O; Galati G; Moridani MY; Siraki A; O'Brien PJ
    Chem Biol Interact; 2004 Jun; 148(1-2):57-67. PubMed ID: 15223357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel prenylated bichalcone and chalcone from Humulus lupulus and their quinone reductase induction activities.
    Yu L; Zhang F; Hu Z; Ding H; Tang H; Ma Z; Zhao X
    Fitoterapia; 2014 Mar; 93():115-20. PubMed ID: 24397993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro.
    Brooks JD; Goldberg MF; Nelson LA; Wu D; Nelson WG
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):868-75. PubMed ID: 12223431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice.
    Cuendet M; Guo J; Luo Y; Chen S; Oteham CP; Moon RC; van Breemen RB; Marler LE; Pezzuto JM
    Cancer Prev Res (Phila); 2010 Feb; 3(2):221-32. PubMed ID: 20068129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of redox homeostasis and carcinogen metabolizing enzymes changes by administration of vitamin E to rats.
    Vivarelli F; Canistro D; Franchi P; Sapone A; Vornoli A; Della Croce C; Longo V; Lucarini M; Paolini M
    Life Sci; 2016 Jan; 145():166-73. PubMed ID: 26702769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent.
    Horley NJ; Beresford KJM; Kaduskar S; Joshi P; McCann GJP; Ruparelia KC; Williams IS; Gatchie L; Sonawane VR; Bharate SB; Chaudhuri B
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5409-5414. PubMed ID: 29138024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chalcones: an update on cytotoxic and chemoprotective properties.
    Go ML; Wu X; Liu XL
    Curr Med Chem; 2005; 12(4):481-99. PubMed ID: 15720256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticarcinogenic biological response of Mikania cordata: reflections in hepatic biotransformation systems.
    Bishayee A; Chatterjee M
    Cancer Lett; 1994 Jun; 81(2):193-200. PubMed ID: 8012937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines.
    Yannai S; Day AJ; Williamson G; Rhodes MJ
    Food Chem Toxicol; 1998 Aug; 36(8):623-30. PubMed ID: 9734712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different effects of two cyclic chalcone analogues on redox status of Jurkat T cells.
    Rozmer Z; Berki T; Maász G; Perjési P
    Toxicol In Vitro; 2014 Dec; 28(8):1359-65. PubMed ID: 25014873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (Iso)flav(an)ones, chalcones, catechins, and theaflavins as anticarcinogens: mechanisms, anti-multidrug resistance and QSAR studies.
    Mercader AG; Pomilio AB
    Curr Med Chem; 2012; 19(25):4324-47. PubMed ID: 22830339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer.
    Malla RR; Siragam S; Dadi V; Seetini B
    Crit Rev Immunol; 2022; 42(6):27-39. PubMed ID: 37082949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of dialkyl diacetylene diols with potent cancer chemopreventive activity.
    Lee CY; Yun JH; Kang K; Nho CW; Shin D
    Bioorg Med Chem Lett; 2015 Sep; 25(18):4020-3. PubMed ID: 26253633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid detection of inducers of enzymes that protect against carcinogens.
    Prochaska HJ; Santamaria AB; Talalay P
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2394-8. PubMed ID: 1549602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer chemopreventive activity of sulforamate derivatives.
    Moriarty RM; Naithani R; Kosmeder J; Prakash O
    Eur J Med Chem; 2006 Jan; 41(1):121-4. PubMed ID: 16300858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.